This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Emilie Joly: Innovator in Pharmaceutical Chemistry
Introduction
Emilie Joly is a prominent inventor based in Colmar, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. Her work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Emilie Joly holds a patent for "Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease." This invention relates to novel trifluoromethyl-oxadiazole derivatives of formula (I), along with their pharmaceutically acceptable salts. The patent outlines pharmaceutical compositions and combinations that utilize these derivatives as medicaments, specifically targeting neurodegeneration, muscle atrophy, and metabolic syndrome through the inhibition of HDAC4. She has 1 patent to her name.
Career Highlights
Emilie Joly is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Emilie has collaborated with notable colleagues, including Joerg Kallen and James Gilbert Ternois. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries in the pharmaceutical field.
Conclusion
Emilie Joly's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in addressing complex health challenges. Her work continues to inspire advancements in medical treatments and therapies.